|
OTC Daily Birth Control Pill Available in Early 2024
|
|
The FDA approved the first daily norgestrel oral contraceptive for use without a prescription, and pharmacists might want to know when it will be available from the manufacturer and what they should advise purchasers. Learn more about information on availability, as well as what the FDA wants women to know before they use it.
|
|
|
Multiple Sclerosis Patients Prefer Oral Medications Versus Injections
|
|
|
More and more multiple sclerosis patients have switched to the use of oral disease-modifying therapies instead of injectable treatments, according to a new study that looks at how the pattern of treatment changed for the chronic disease of the central nervous system. Learn more about these study results published in the Journal of the American Medical Association Neurology.
|
|
One-Third of Hepatitis C Patients Received Curative Treatment
|
|
|
An antiviral medication that cures more than 95% of hepatitis C cases has been available for nearly a decade. Yet, only about one-third of hepatitis C virus patients in the United States have benefited from it. A recent study raises the question of why and promotes a national campaign to eliminate the infection, which can lead to liver failure and cancer. Read more.
|
|
|
Who Is Most Likely to Have Severe Cases of COVID-19?
|
|
Over the course of the COVID-19 pandemic, many different cohorts have been identified as most at risk of having severe COVID-19. A new study published in the Journal of the American Medical Association Network Open involving analysis of more than 50,000 participants in SARS-CoV-2 vaccine trials provides some solid evidence. Learn more about what the researchers found out.
|
|
.jpg)
